These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 9035224)

  • 21. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP; Tsoi WF
    Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moclobemide safety: monitoring a newly developed product in the 1990s.
    Hilton S; Jaber B; Ruch R
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):76S-83S. PubMed ID: 7593735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moclobemide: relationships between dose, drug concentration in plasma, and occurrence of adverse events.
    Guentert TW; Banken L; Hilton S; Holford NH
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):84S-94S. PubMed ID: 7593736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential of concentration monitoring data for a short half-life drug: analysis of pharmacokinetic variability for moclobemide.
    Gex-Fabry M; Balant-Gorgia AE; Balant LP
    Ther Drug Monit; 1995 Feb; 17(1):39-46. PubMed ID: 7725375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidelines for the implementation of drug utilization observation (DUO) studies in psychopharmacological therapy. The "Phase IV Research" Task-Force of the Association for Neuropsychopharmacology and Pharmacopsychiatry (AGNP).
    Linden M; Baier D; Beitinger H; Kohnen R; Osterheider M; Philipp M; Reimitz DE; Schaaf B; Weber HJ
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):65-70. PubMed ID: 9035231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of sexual dysfunction in depressed patients and reporting attitudes in routine daily practice: Results of the postmarketing observational studies with moclobemide, a reversible MAO-A inhibitor.
    Philipp M; Delini-Stula A; Baier D; Kohnen R; Scholz HJ; Laux G
    Int J Psychiatry Clin Pract; 1999; 3(4):257-64. PubMed ID: 24921229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moclobemide in the prophylactic treatment of migraine. A retrospective analysis of 44 cases.
    Meienberg O; Amsler F
    Eur Neurol; 1996; 36(2):109-10. PubMed ID: 8654481
    [No Abstract]   [Full Text] [Related]  

  • 28. Erratum to: Moclobemide: An update of its pharmacological properties and therapeutic use.
    Fulton B; Benfield P
    Drugs; 1996 Dec; 52(6):869. PubMed ID: 28597367
    [No Abstract]   [Full Text] [Related]  

  • 29. Graphene supremacy: the duo duo.
    Zhang F; Xie XC
    Natl Sci Rev; 2022 Dec; 9(12):nwac233. PubMed ID: 36519071
    [No Abstract]   [Full Text] [Related]  

  • 30. RIMA: a safe concept in the treatment of depression with moclobemide.
    Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():7-11. PubMed ID: 1394030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What happens to patients after the end of a clinical trial? Systematic follow-up observational study of an open moclobemide trial in major depression.
    Linden M; Baier D; Gothe H; Kohnen R
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):35-43. PubMed ID: 9035226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Customary antidepressive treatment in Hungary: moclobemid therapy in everyday practice].
    Bartkó G
    Orv Hetil; 1997 Sep; 138(37):2341-5. PubMed ID: 9340582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants].
    Becker T; Struck M; Laux G
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():44-7. PubMed ID: 2685856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant drug use: differences between psychiatrists and general practitioners. Results from a drug utilization observation study with fluoxetine.
    Dittmann RW; Linden M; Osterheider M; Schaaf B; Ohnmacht U; Weber HJ
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):28-34. PubMed ID: 9035225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality-monitoring of psychotropic drug therapy in post-marketing surveillance. Results of a drug utilization observation (DUO) study on moclobemide.
    Laux G; Baier D
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):21-7. PubMed ID: 9035224
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.